US Patent 9125915 Antitumor agent
Patent 9125915 was granted and assigned to Mitsubishi Tanabe Pharma on September, 2015 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9125915 Antitumor agent
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
